Hypertrophic Cardiomyopathy (HCM) Clinical Trials

Find Hypertrophic Cardiomyopathy (HCM) Clinical Trials Near You

A Non-interventional Observational Study of the Sustained Use of Prolaio Digital Health Devices to Monitor the Natural History of Chronic Cardiovascular Conditions in Ambulatory Patients

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 years of age and older

• Ability to understand study assessments and give informed consent to data collection

• Ability to comply with the study protocol

• Ability to understand and respond to instructions in English

• Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc.

• Resides in the United States

Locations
United States
Illinois
Prolaio
RECRUITING
Chicago
Contact Information
Primary
Study Team OCORO Study
OCOROstudy@prolaio.com
1-855-869-9054
Time Frame
Start Date: 2025-10-30
Estimated Completion Date: 2030-10
Participants
Target number of participants: 5000
Treatments
Cardiovascular Disease (CVD)
Participants who have been diagnosed including but not limited to the following Cardiovascular Disease types: Aortic Stenosis, Heart Failure, Hypertension Obstructive Cardiomyopathy, Dilated Cardiomyopathy
Sponsors
Leads: Prolaio

This content was sourced from clinicaltrials.gov